Induction of CYP2D6 Expression during Pregnancy Is Associated with an Increased Activity of Hepatocyte Nuclear Factor 4α

被引：0
|
作者：
Pan, Xian [1 ]
Koh, Kwihye [2 ]
Yu, Ai-Ming [3 ]
Jeong, Hyunyoung [1 ,2 ]
机构：
[1] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL USA
[2] Univ Illinois, Dept Pharm Practice, Chicago, IL USA
[3] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1102.3
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity
    Doki, Kosuke
    Sekiguchi, Yukio
    Kuga, Keisuke
    Aonuma, Kazutaka
    Homma, Masato
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (04) : 257 - 262
  • [32] The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer
    AbdelRahman, SZ
    Anwar, WA
    AbdelAal, WE
    Ghoneim, MA
    Au, WW
    CANCER LETTERS, 1997, 119 (01) : 115 - 122
  • [33] The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6
    Fukuda, T
    Nishida, Y
    Imaoka, S
    Hiroi, T
    Naohara, M
    Funae, Y
    Azuma, J
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 380 (02) : 303 - 308
  • [34] Constituents of Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activity
    Subehan
    Usia, T
    Kadota, S
    Tezuka, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2005, 53 (03) : 333 - 335
  • [35] Common mutant alleles of CYP2D6 causing the defect of CYP2D6 enzyme activity in a Japanese population
    Ishiguro, A
    Kubota, T
    Sasaki, H
    Yamada, Y
    Iga, T
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 414 - U3
  • [36] A novel CYP2D6 scoring system for the prediction of CYP2D6 activity: Application to tamoxifen metabolism.
    Borges, S.
    Li, L.
    Robarge, J.
    Nguyen, A.
    Azzouz, F.
    Desta, Z.
    Skaar, T.
    Flockhart, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S67 - S67
  • [37] Evidence for CYP2D6 expression in human lung
    Lo Guidice, JM
    Marez, D
    Sabbagh, N
    Legrand-Andreoletti, M
    Spire, C
    Alcaïde, E
    Lafitte, JJ
    Broly, F
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (01) : 79 - 85
  • [38] EXPRESSION OF CYP2D6 IN DEVELOPING HUMAN LIVER
    TRELUYER, JM
    JACQZAIGRAIN, E
    ALVAREZ, F
    CRESTEIL, T
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 202 (02): : 583 - 588
  • [39] CYP2D6 polymorphism is not associated with essential tremor
    Agundez, JAG
    JimenezJimenez, FJ
    Tejeda, R
    Ledesma, MC
    OrtiPareja, M
    Gasalla, T
    Molina, JA
    Ruiz, J
    Coria, F
    Duarte, J
    Vazquez, A
    Ladero, JM
    Benitez, J
    EUROPEAN NEUROLOGY, 1997, 38 (02) : 99 - 104
  • [40] CYP2D6 polymorphisms associated with tamoxifen outcome
    Hutchinson L.
    Nature Reviews Clinical Oncology, 2009, 6 (12) : 675 - 675
12345